[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fEAMC0M17jMkI3-ByQDa5iLDzh2r-K5yOnXvSRE450P0":8,"$ftEjENxtH78rvI_e6Q98IcPE7yJv3JCXasYxNWL0Duhg":55,"$f_KDC7PvOKkFTvjZZnz1VkGpMkqrJ8XwdzLirKfzfBlU":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},57775,870358,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//KGvUiQyxX7cgFOiNjW883bSOhp4xZi3T.png","罗旭","大连医科大学附属第一医院","肝胆外科","住院医师",53,0,"肠癌肝转移治疗用药细节全解：剂型、使用方法与安全须知","","https://ystcdn.venuertc.com/venue/AI/ce4a97d2-9a40-477c-bee3-e0686ff8dbd1.jpg","\u003Cdiv id=\"material_title\" class=\"colorectal-title\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肠癌肝转移治疗用药细节全解：剂型、使用方法与安全须知\u003C/h2>\n  \u003Cp class=\"colorectal-intro\">\n    说起来针对肠癌肝转移的药物，涉及化疗、靶向以及免疫制剂等多种类型。每一种药品的使用細节都决定了疗效和安全性。这篇指南将依次讲解肠癌肝转移常用药品的剂型、服用方法、不良反应处理、药物相互作用、特殊人群用药调整及储存方法等7个关键环节。帮您快速抓住用药的重点，避开实际操作中的常见风险。\n  \u003C/p>\n\u003C/div>\n\n\u003Csection class=\"colorectal-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 化疗药品的剂型与正确使用方式 \u003Cspan class=\"colorectal-emoji\">💊\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"colorectal-bg colorectal-bg1\">\u003C/div>\n  \u003Cp>\n    化疗常用药包括卡培他滨（口服片剂）、伊立替康脂质体（注射剂）、奥沙利铂（注射剂）等。\n    \u003Cbr>\u003Cbr>\n    \u003Cstrong>剂型简析：\u003C/strong>\n    \u003C/p>\u003Cul>\n      \u003Cli>\u003Cb>卡培他滨：\u003C/b>粉色薄膜包衣片剂，口服。\u003C/li>\n      \u003Cli>\u003Cb>奥沙利铂：\u003C/b>无色透明液体，需静脉滴注，配合输液泵。\u003C/li>\n      \u003Cli>\u003Cb>伊立替康脂质体：\u003C/b>注射用，乳白色均匀混悬液。\u003C/li>\n    \u003C/ul>\n    \u003Cstrong>使用要点：\u003C/strong>\n    \u003Cul>\n      \u003Cli>卡培他滨必须整片吞服，不可咀嚼也不可掰断。\u003C/li>\n      \u003Cli>口服卡培他滨推荐在餐后30分钟内服用，建议用200 ml清水送服。\u003C/li>\n      \u003Cli>奥沙利铂与伊立替康脂质体均需严格按照静脉注射流程操作，不可自行注射。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"colorectal-tip\">正确做法：\u003C/span>遵医嘱备足饮水，确保每次服药定点、剂量准确，注射类药物需专业人员操作。\n  \u003Cp>\u003C/p>\n\u003C/section>\n\n\u003Csection class=\"colorectal-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 靶向与免疫药物：规格及用法分析 \u003Cspan class=\"colorectal-emoji\">🧬\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"colorectal-bg colorectal-bg2\">\u003C/div>\n  \u003Cp>\n    免疫治疗和抗血管生成靶向药近年来应用广泛。像PD-1抑制剂（如帕博利珠单抗、纳武利尤单抗）、贝伐珠单抗等注射类药品，各自有特定规格和使用要求。\n    \u003Cbr>\u003Cbr>\n    \u003Cstrong>剂型说明：\u003C/strong>\n    \u003C/p>\u003Cul>\n      \u003Cli>\u003Cb>PD-1抑制剂：\u003C/b>无菌冻干粉，需溶解稀释后静脉滴注。\u003C/li>\n      \u003Cli>\u003Cb>贝伐珠单抗：\u003C/b>无色或淡黄色液体，静脉滴注。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"colorectal-tip\">使用方法：\u003C/span>全部需要医院专业人员操作，不可自行处理。静脉滴注时间通常为30-90分钟，根据具体药品及疗程调整。\n    \u003Cbr>\n    \u003Cstrong>正确做法：\u003C/strong>到正规医疗机构注射，每次确认药品批号、剂型、有效期，并与药师沟通调整方案。\n  \u003Cp>\u003C/p>\n\u003C/section>\n\n\u003Csection class=\"colorectal-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 化疗与靶向药的药理机制简述 \u003Cspan class=\"colorectal-emoji\">⚙️\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"colorectal-bg colorectal-bg3\">\u003C/div>\n  \u003Cp>\n    药品发挥效果的方式多种多样，理解这些机制有助于规避错误操作。\u003Cbr>\u003Cbr>\n    \u003Cstrong>卡培他滨：\u003C/strong>体内转化为5-氟尿嘧啶，干扰DNA合成。\u003Cbr>\n    \u003Cstrong>奥沙利铂：\u003C/strong>使DNA链交联，降低细胞分裂速度。\u003Cbr>\n    \u003Cstrong>伊立替康脂质体：\u003C/strong>抑制拓扑异构酶Ⅰ，阻止细胞复制。\u003Cbr>\n    \u003Cstrong>抗血管生成制剂（贝伐珠单抗）：\u003C/strong>阻断VEGF信号，减少新生血管供给。\u003Cbr>\n    \u003Cstrong>PD-1抑制剂：\u003C/strong>阻断PD-1与配体结合，激活T细胞用于增强免疫反应。\n    \u003Cbr>\n    \u003Cspan class=\"colorectal-note\">这些作用不会对服药方式产生直接影响，但决定了联合使用和不良反应风险。\u003C/span>\n  \u003C/p>\n\u003C/section>\n\n\u003Csection class=\"colorectal-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用的注意细节 \u003Cspan class=\"colorectal-emoji\">🔗\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"colorectal-bg colorectal-bg4\">\u003C/div>\n  \u003Cp>\n    联合用药时，药物之间可能产生相互影响。\u003Cbr>\u003Cbr>\n    \u003Cstrong>常见相互作用：\u003C/strong>\n    \u003C/p>\u003Cul>\n      \u003Cli>卡培他滨与华法林同时使用时可使抗凝作用增强，需密切监测凝血指标。\u003C/li>\n      \u003Cli>伊立替康脂质体与抗癫痫药物（如苯妥英）共同用药会影响药效。\u003C/li>\n      \u003Cli>贝伐珠单抗与其他抗血管生成药物联合使用需要间隔给药，防止加重高血压或出血风险。\u003C/li>\n      \u003Cli>奥沙利铂可增强某些利尿剂的肾毒性。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"colorectal-tip\">正确做法：\u003C/span>每次就诊前提前列出当前服用的所有药品，并向医生、药师报告，避免自作主张同时用药。\n  \u003Cp>\u003C/p>\n\u003C/section>\n\n\u003Csection class=\"colorectal-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 特殊人群用药调整指南 \u003Cspan class=\"colorectal-emoji\">👵\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"colorectal-bg colorectal-bg5\">\u003C/div>\n  \u003Cp>\n    老年人和肝、肾功能不全者用药需要格外留意。\n    \u003Cbr>\u003Cbr>\n    \u003Cstrong>调整原则：\u003C/strong>\n    \u003C/p>\u003Cul>\n      \u003Cli>老年患者容易发生药物堆积，建议首剂减量，逐步增加，根据反应随时调整。\u003C/li>\n      \u003Cli>肝功能不全患者使用伊立替康脂质体要根据转氨酶、胆红素水平酌情减量。\u003C/li>\n      \u003Cli>肾功能受损者使用奥沙利铂需监控肾功并调整剂量。\u003C/li>\n      \u003Cli>孕妇、哺乳期女性不建议使用上述药物。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"colorectal-tip\">正确做法：\u003C/span>首次用药前主动向医生说明自身情况，不得自行超剂量或减剂量服药。\n    \u003Cbr>\n    \u003Cspan class=\"colorectal-note\">实际用药案例如下：\u003C/span>\n    \u003Cul>\n      \u003Cli>68岁高体重女性用卡培他滨时，化疗剂量调整为低剂量方案减少心血管不良反应风险。\u003C/li>\n      \u003Cli>临床上老年患者使用贝伐珠单抗时，首剂减量并定期检测血压，以预防高血压。\u003C/li>\n    \u003C/ul>\n  \u003Cp>\u003C/p>\n\u003C/section>\n\n\u003Csection class=\"colorectal-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应与处理方法 \u003Cspan class=\"colorectal-emoji\">🔍\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"colorectal-bg colorectal-bg6\">\u003C/div>\n  \u003Cp>\n    有些副作用不可避免，但合理应对可以显著降低风险。\u003Cbr>\u003Cbr>\n    \u003Cstrong>常见不良反应：\u003C/strong>\n    \u003C/p>\u003Cul>\n      \u003Cli>卡培他滨：手足皮肤麻木、脱皮，偶见肝酶升高。\u003C/li>\n      \u003Cli>奥沙利铂：手麻、刺痛，部分患者出现低体温。\u003C/li>\n      \u003Cli>贝伐珠单抗：可能引发高血压、出血、蛋白尿。\u003C/li>\n      \u003Cli>PD-1抑制剂：免疫相关发热，偶见皮疹。\u003C/li>\n      \u003Cli>伊立替康脂质体：腹泻、白细胞减少。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"colorectal-tip\">正确做法：\u003C/span>\n    \u003Cul>\n      \u003Cli>出现副作用时不要自行停药，应及时联系医生或药师。\u003C/li>\n      \u003Cli>对于皮肤反应，可使用保护霜；腹泻时补充水和电解质。\u003C/li>\n      \u003Cli>高血压发生时需随时量血压并报告。\u003C/li>\n    \u003C/ul>\n    \u003Cbr>\n    \u003Cspan class=\"colorectal-note\">临床数据显示：\u003C/span>\n    \u003Cul>\n      \u003Cli>卡培他滨相关手足综合征发生率约40%（Van Cutsem et al., 2004）\u003C/li>\n    \u003C/ul>\n  \u003Cp>\u003C/p>\n\u003C/section>\n\n\u003Csection class=\"colorectal-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 药品储存方式与有效期管理 \u003Cspan class=\"colorectal-emoji\">📦\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"colorectal-bg colorectal-bg7\">\u003C/div>\n  \u003Cp>\n    储存不当会导致药品失效甚至变质。\u003Cbr>\u003Cbr>\n    \u003Cstrong>储存方法：\u003C/strong>\n    \u003C/p>\u003Cul>\n      \u003Cli>卡培他滨片：需放在干燥阴凉处，避免阳光直射。\u003C/li>\n      \u003Cli>奥沙利铂和贝伐珠单抗注射液：放置于2-8°C冰箱冷藏，严禁冷冻。\u003C/li>\n      \u003Cli>PD-1抑制剂冻干粉：按药品说明冷藏，开封后限时使用完毕。\u003C/li>\n      \u003Cli>溶液配制好后1小时内必须用完。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"colorectal-tip\">正确做法：\u003C/span>每次取药前核对有效期，发现变色、异味或失效药物，立即丢弃，不要随便处理剩药，建议交至药房处理。\n  \u003Cp>\u003C/p>\n\u003C/section>\n\n\u003Csection class=\"colorectal-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服与过量用药的应对措施 \u003Cspan class=\"colorectal-emoji\">⏰\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"colorectal-bg colorectal-bg8\">\u003C/div>\n  \u003Cp>\n    日常服药状况复杂，偶尔漏服或误服药物并不少见。\n    \u003Cbr>\u003Cbr>\n    \u003Cstrong>应对办法：\u003C/strong>\n    \u003C/p>\u003Cul>\n      \u003Cli>卡培他滨漏服很常见，发现当日及时补服，绝不应加倍剂量。\u003C/li>\n      \u003Cli>注射类药物漏针不得自行补打，下次按正常时间施用。\u003C/li>\n      \u003Cli>如误服过量，应立即就医，带上药品盒和说明书。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"colorectal-tip\">正确做法：\u003C/span>\n    \u003Cul>\n      \u003Cli>设定手机闹钟或服药记录，减少遗漏。\u003C/li>\n      \u003Cli>建议药品包装上写好每日剂量和时间。\u003C/li>\n    \u003C/ul>\n  \u003Cp>\u003C/p>\n\u003C/section>\n\n\u003Csection class=\"colorectal-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 总结：肠癌肝转移药品操作关键点 \u003Cspan class=\"colorectal-emoji\">✅\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"colorectal-bg colorectal-bg9\">\u003C/div>\n  \u003Cp>\n    全过程用药管理就是保障治疗安全的基础。每一次药物服用、注射、储存、处理小细节都关系着整体疗效。\n    \u003Cbr>\n    \u003Cstrong>再次提醒：\u003C/strong>\n    \u003C/p>\u003Cul>\n      \u003Cli>所有静脉注射药物必须由专业人员操作，家庭环境不可替代。\u003C/li>\n      \u003Cli>定期接受药师用药咨询，出现副作用立即就医。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"colorectal-tip\">\n      合理用药、规范操作才能最大程度发挥疗效，也能显著减轻不良反应风险。\n    \u003C/span>\n  \u003Cp>\u003C/p>\n\u003C/section>\n\n\u003Csection class=\"colorectal-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">文献引用 \u003Cspan class=\"colorectal-emoji\">📚\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"colorectal-bg colorectal-bg10\">\u003C/div>\n  \u003Cul class=\"colorectal-ref\">\n    \u003Cli>Van Cutsem, E., Twelves, C., Cassidy, J., et al. (2004). Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. \u003Ci>Journal of Clinical Oncology, 19(21), 4097–4106.\u003C/i>\u003C/li>\n    \u003Cli>Hurwitz, H., Fehrenbacher, L., Novotny, W., et al. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. \u003Ci>New England Journal of Medicine, 350(23), 2335–2342.\u003C/i>\u003C/li>\n    \u003Cli>Borghaei, H., Paz-Ares, L., Horn, L., et al. (2015). Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer. \u003Ci>New England Journal of Medicine, 373(17), 1627-1639.\u003C/i>\u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Cstyle>\n.colorectal-title {\n  background: linear-gradient(90deg,#f6e8da 0%,#e9f5ea 100%);\n  border-radius: 12px;\n  box-shadow: 0 4px 28px rgba(59, 112, 167, 0.08);\n  padding: 32px 24px;\n  margin-bottom: 24px;\n}\n.colorectal-intro {\n  color: #555a6a;\n  font-size: 19px;\n  margin-top: 14px;\n  font-weight: 500;\n}\n\n.colorectal-section {\n  margin-bottom: 32px;\n  border-radius: 14px;\n  background-color: #faf6f2;\n  box-shadow: 0 2px 8px rgba(152, 183, 183, 0.09);\n  padding: 18px 26px 24px 26px;\n  position: relative;\n  overflow: hidden;\n}\n\n.colorectal-section h2 {\n  font-size: 24px;\n  font-weight: 600;\n  color: #207586;\n  margin-bottom: 12px;\n  padding-top: 16px;\n}\n\n.colorectal-emoji {\n  margin-left: 8px;\n  font-size: 22px;\n  vertical-align: middle;\n}\n\n.colorectal-tip {\n  color: #926716;\n  font-weight: bold;\n}\n\n.colorectal-note {\n  color: #414fc0;\n  font-weight: bold;\n}\n\n.colorectal-bg {\n  position: absolute;\n  left: 0; right: 0; top: 0;\n  height: 60px;\n  background-repeat: no-repeat;\n  background-size: cover;\n  opacity: 0.12;\n  z-index: 0;\n}\n.colorectal-bg1 {background-image: linear-gradient(90deg, #c0e5da, #f6e8da);}\n.colorectal-bg2 {background-image: linear-gradient(90deg, #eec7c7, #bbe2e9);}\n.colorectal-bg3 {background-image: linear-gradient(90deg, #f1eff5, #cdeddc);}\n.colorectal-bg4 {background-image: linear-gradient(90deg, #e6dee1, #c5d8e5);}\n.colorectal-bg5 {background-image: linear-gradient(90deg, #f5e7d9, #e3e8ef);}\n.colorectal-bg6 {background-image: linear-gradient(90deg, #f8e9e3, #dbe3ed);}\n.colorectal-bg7 {background-image: linear-gradient(90deg,#e9efda,#eab4be);}\n.colorectal-bg8 {background-image: linear-gradient(90deg,#ddf2fd,#e9ceec);}\n.colorectal-bg9 {background-image: linear-gradient(90deg,#f7ecd8,#dedbf1);}\n.colorectal-bg10{background-image: linear-gradient(90deg,#faf6f2,#e7f0f7);}\n\n.colorectal-section ul {\n  padding-left: 18px;\n  margin-bottom: 12px;\n}\n.colorectal-section li {\n  line-height: 1.9;\n  margin-bottom: 6px;\n}\n\n.colorectal-ref {\n  background: #f5f9fa;\n  border-radius: 10px;\n  margin: 22px 0 0 0;\n  padding: 14px 24px;\n  font-size: 16px;\n}\n.colorectal-ref i {\n  color: #4c686e;\n  font-style: italic;\n}\n\u003C/style>\n","\u003Cdiv id=\"material_title\" class=\"colorectal-title\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2e",534,"2025-08-09 16:05:30","肠癌, 肝转移, 化疗药物, 靶向药物, 用药安全","本指南详细解析了肠癌肝转移的化疗与靶向药物使用细节，包括药品剂型、服用方法及不良反应处理，帮助患者和家属安全有效地进行治疗。","2025-08-17 07:05:56",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]